MEDIROM MOTHER Labs Surpasses 100 Business Contracts and Supports Over 10,000 Individuals with "Lav" App

Reuters
05-30
MEDIROM MOTHER Labs Surpasses 100 Business Contracts and Supports Over 10,000 Individuals with "Lav" App

MEDIROM Healthcare Technologies Inc.'s subsidiary, MEDIROM MOTHER Labs, Inc., has achieved significant milestones with its specific health guidance service utilizing the "Lav" healthcare app. Since its launch in 2019, the service has garnered over 100 contracted companies and supported more than 10,000 individuals. The app provides continuous health support through information and communication technology, receiving high praise from health insurance associations and company employees. The initiative is part of a broader effort to prevent lifestyle-related diseases and promote health management, aiming to establish healthy behaviors through diet and exercise guidance. As of April 2025, approximately 1 out of every 14 health insurance associations in Japan is a partner of the "Lav" app.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-008263), on May 30, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10